Cemiplimab Therapeutic Cheat Sheet
Cemiplimab is a monoclonal antibody therapy that has emerged as a promising treatment option for certain types of advanced skin cancer. Specifically designed to target the programmed cell death protein 1 (PD-1) pathway, cemiplimab works by blocking the interaction between PD-1 and its ligands, PD-L1 and PD-L2, thereby unleashing the body's immune system to recognize and attack cancer cells. We con …
Cemiplimab is a monoclonal antibody therapy that has emerged as a promising treatment option for certain types of advanced skin cancer. Specifically designed to target the programmed cell death protein 1 (PD-1) pathway, cemiplimab works by blocking the interaction between PD-1 and its ligands, PD-L1 and PD-L2, thereby unleashing the body's immune system to recognize and attack cancer cells. We con … 
CNBC recently wrote an article about the safety of keratin hair treatments in light of a proposed FDA rule that would ban products that contain or release formaldehyde. Which straightening products would be affected by a ban? What should dermatologists know about safety concerns with other hair straightening products?
Amy McMichael, MD, FAAD, professor of dermatology at Wake Forest University S … 
What is the underlying defect for the disease shown in picture is?
A. ATP2A2
B. ATP2C1
C. BPAG1
D. BPAG2
E. Collagen type 17
To find out the correct answer and read the explanation, click here. … 
You may want to make an extra effort to encourage your young adult patients to protect their skin from the sun. Recent surveys, as noted in The New York Times, showed that adults born after 1997 – those considered in Gen Z – were more likely to believe sun safety myths, including that daily sunscreen usage is more harmful than sun exposure.
Experts say that misinformation in this age group … 
Histopathology can be rendered useless without good clinical information, according to Dr. Olayemi Sokumbi, a dermatologist and dermatopathologist with Mayo Clinic. Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. Sokumbi about traps to avoid in challenging clinicopathologic scenarios. Learn how not to miss a diagnosis of dermatomyosit …